Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis.

Quo vadis autoimmune hepatitis? - Summary of the 5(th) international autoimmune hepatitis group research workshop 2024.

Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.

Recommendations and quality criteria to improve the early diagnosis of primary biliary cholangitis.

Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitis.

Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.

Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis.

Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.

Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study.

CYCLOPS: A cyclists' orientation data acquisition system using RGB camera and inertial measurement units (IMU).

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU.

Development of a Resveratrol Nanoformulation for the Treatment of Diabetic Retinopathy.

Surgical Treatment of Persistent Pseudomonas aeruginosa Bacteraemia After n-Butyl-2-cyanoacrylate for Gastric Bleeding Varices.

Setting up regional diagnostic reference levels for pediatric computed tomography in Latin America: preliminary results, challenges and the work ahead.

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU.